87 related articles for article (PubMed ID: 18090216)
1. Is thyroglobulin the stronger indicator for progressive disease than the other conventional factors in same age patient groups with differentiated thyroid cancer?
Aras G; Gültekin SS; Küçük NO; Genç Y
Nucl Med Commun; 2007 Dec; 28(12):907-13. PubMed ID: 18090216
[TBL] [Abstract][Full Text] [Related]
2. Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma.
Heemstra KA; Liu YY; Stokkel M; Kievit J; Corssmit E; Pereira AM; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2007 Jan; 66(1):58-64. PubMed ID: 17201802
[TBL] [Abstract][Full Text] [Related]
3. The additive clinical value of combined thyroglobulin and antithyroglobulin antibody measurements to define persistent and recurrent disease in patients with differentiated thyroid cancer.
Aras G; Gültekin SS; Küçük NO
Nucl Med Commun; 2008 Oct; 29(10):880-4. PubMed ID: 18769305
[TBL] [Abstract][Full Text] [Related]
4. High-sensitive 2nd generation thyroglobulin immunoradiometric assay. Clinical application in differentiated thyroid cancer management.
Giovanella L; Ceriani L; Garancini S
Q J Nucl Med; 2002 Dec; 46(4):319-22. PubMed ID: 12411872
[TBL] [Abstract][Full Text] [Related]
5. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of serum thyroglobulin after surgery for thyroid carcinoma.
Hall FT; Beasley NJ; Eski SJ; Witterick IJ; Walfish PG; Freeman JL
Laryngoscope; 2003 Jan; 113(1):77-81. PubMed ID: 12514386
[TBL] [Abstract][Full Text] [Related]
7. Thyroglobulin before ablation and correlation with posttreatment scanning.
de Rosário PW; Guimarães VC; Maia FF; Fagundes TA; Purisch S; Padrao EL; Rezende LL; Barroso AL
Laryngoscope; 2005 Feb; 115(2):264-7. PubMed ID: 15689747
[TBL] [Abstract][Full Text] [Related]
8. [Thyroglobulin: usefulness and limits in monitoring patients with thyroid carcinoma].
Hammami H; Sellem A; Ben Sellem D; Aouni Z; Elabri SB; Mezigh C; Machghoul S; Ben Brahim H
Tunis Med; 2007 Feb; 85(2):128-30. PubMed ID: 17665659
[TBL] [Abstract][Full Text] [Related]
9. Does a highly sensitive thyroglobulin (Tg) assay change the clinical management of low-risk patients with thyroid cancer with Tg on T4 < 1 ng/ml determined by traditional assays?
Rosario PW; Purisch S
Clin Endocrinol (Oxf); 2008 Mar; 68(3):338-42. PubMed ID: 17850379
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors of carcinoma in 327 patients with follicular neoplasm of the thyroid.
Besic N; Sesek M; Peric B; Zgajnar J; Hocevar M
Med Sci Monit; 2008 Sep; 14(9):CR459-67. PubMed ID: 18758416
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human TSH-assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone withdrawal.
Tuttle RM; Brokhin M; Omry G; Martorella AJ; Larson SM; Grewal RK; Fleisher M; Robbins RJ
J Nucl Med; 2008 May; 49(5):764-70. PubMed ID: 18413378
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of two methods to assay thyroglobulin serum concentrations in patients with differentiated thyroid carcinomas.
Ferrari L; Seregni E; Aliberti G; Martinetti A; Pallotti F; Villano C; Lucignani G; Bombardieri E
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):237-42. PubMed ID: 15499298
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors determining survival in differentiated thyroid cancer.
Gulcelik MA; Gulcelik NE; Kuru B; Camlibel M; Alagol H
J Surg Oncol; 2007 Dec; 96(7):598-604. PubMed ID: 17708543
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of postsurgical stimulated thyroglobulin levels after initial radioactive iodine therapy in well-differentiated thyroid carcinoma.
Sawka AM; Orlov S; Gelberg J; Stork B; Dowar M; Shaytzag M; Tabatabaie V; Freeman JL; Walfish PG
Head Neck; 2008 Jun; 30(6):693-700. PubMed ID: 18098308
[TBL] [Abstract][Full Text] [Related]
15. Risk of malignancy in follicular thyroid neoplasm: predictive value of thyrotropin.
Zimny M; Selkinski I; Blasius S; Rink T; Schroth HJ; Grünwald F
Nuklearmedizin; 2012; 51(4):119-24. PubMed ID: 22526481
[TBL] [Abstract][Full Text] [Related]
16. Clinical implication of F-18 FDG PET/CT for differentiated thyroid cancer in patients with negative diagnostic iodine-123 scan and elevated thyroglobulin.
Kim SJ; Lee TH; Kim IJ; Kim YK
Eur J Radiol; 2009 Apr; 70(1):17-24. PubMed ID: 18207685
[TBL] [Abstract][Full Text] [Related]
17. Hurthle cell neoplasm of the thyroid gland.
Ahmed M; Bin Yousef H; Greer W; Faraz H; Al Sobhi S; Al Zahrani A; Raef H; Al Ghamdi A; Al Kadhi Y; Al Dayel F
ANZ J Surg; 2008 Mar; 78(3):139-43. PubMed ID: 18269475
[TBL] [Abstract][Full Text] [Related]
18. [Age and sex distribution of primary thyroid cancer in relation to histological type].
Freitag T; Baier A; Dewitz D
Zentralbl Chir; 1999; 124(4):331-5. PubMed ID: 10355089
[TBL] [Abstract][Full Text] [Related]
19. Outcome and survival of patients aged 75 years and older compared to younger patients after ruptured abdominal aortic aneurysm repair: do the results justify the effort?
Shahidi S; Schroeder TV; Carstensen M; Sillesen H
Ann Vasc Surg; 2009; 23(4):469-77. PubMed ID: 19136232
[TBL] [Abstract][Full Text] [Related]
20. Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer.
Spencer CA; Lopresti JS
Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):223-33. PubMed ID: 18268520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
